TD Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.5M | Sell |
123,884
-14,600
| -11% | -$531K | ﹤0.01% | 780 |
|
|
2025
Q1 | $5.01M | Buy |
138,484
+45,000
| +48% | +$1.63M | ﹤0.01% | 786 |
|
|
2024
Q4 | $3.93M | Sell |
93,484
-75,600
| -45% | -$3.18M | ﹤0.01% | 840 |
|
|
2024
Q3 | $9.2M | Buy |
169,084
+20,000
| +13% | +$1.09M | 0.01% | 660 |
|
|
2024
Q2 | $6.13M | Sell |
149,084
-71,276
| -32% | -$2.93M | 0.01% | 717 |
|
|
2024
Q1 | $10.3M | Sell |
220,360
-1,000
| -0.5% | -$46.7K | 0.01% | 620 |
|
|
2023
Q4 | $10.6M | Buy |
221,360
+16,000
| +8% | +$765K | 0.01% | 607 |
|
|
2023
Q3 | $7.32M | Buy |
205,360
+87,580
| +74% | +$3.12M | 0.01% | 644 |
|
|
2023
Q2 | $5.43M | Buy |
117,780
+19,002
| +19% | +$877K | 0.01% | 718 |
|
|
2023
Q1 | $3.96M | Sell |
98,778
-31,372
| -24% | -$1.26M | ﹤0.01% | 798 |
|
|
2022
Q4 | $6.03M | Sell |
130,150
-132,214
| -50% | -$6.13M | 0.01% | 695 |
|
|
2022
Q3 | $10.6M | Sell |
262,364
-41,863
| -14% | -$1.7M | 0.01% | 571 |
|
|
2022
Q2 | $18.2M | Sell |
304,227
-54,114
| -15% | -$3.23M | 0.02% | 453 |
|
|
2022
Q1 | $26M | Sell |
358,341
-15,430
| -4% | -$1.12M | 0.02% | 418 |
|
|
2021
Q4 | $31.4M | Buy |
373,771
+129,824
| +53% | +$10.9M | 0.03% | 401 |
|
|
2021
Q3 | $22M | Buy |
243,947
+9,587
| +4% | +$865K | 0.02% | 449 |
|
|
2021
Q2 | $18.7M | Buy |
234,360
+7,093
| +3% | +$566K | 0.02% | 495 |
|
|
2021
Q1 | $25.9M | Buy |
227,267
+46,789
| +26% | +$5.33M | 0.03% | 415 |
|
|
2020
Q4 | $25M | Buy |
180,478
+43,636
| +32% | +$6.04M | 0.03% | 390 |
|
|
2020
Q3 | $11.2M | Buy |
136,842
+26,500
| +24% | +$2.18M | 0.02% | 514 |
|
|
2020
Q2 | $8.63M | Buy |
110,342
+39,326
| +55% | +$3.08M | 0.01% | 544 |
|
|
2020
Q1 | $3.16M | Sell |
71,016
-54
| -0.1% | -$2.4K | 0.01% | 730 |
|
|
2019
Q4 | $3.04M | Sell |
71,070
-4,100
| -5% | -$175K | ﹤0.01% | 830 |
|
|
2019
Q3 | $3.22M | Sell |
75,170
-8,000
| -10% | -$342K | ﹤0.01% | 792 |
|
|
2019
Q2 | $5.28M | Buy |
83,170
+18,350
| +28% | +$1.17M | 0.01% | 673 |
|
|
2019
Q1 | $4.5M | Buy |
64,820
+7,281
| +13% | +$505K | 0.01% | 719 |
|
|
2018
Q4 | $2.5M | Sell |
57,539
-1,600
| -3% | -$69.6K | ﹤0.01% | 852 |
|
|
2018
Q3 | $4.52M | Sell |
59,139
-242
| -0.4% | -$18.5K | 0.01% | 763 |
|
|
2018
Q2 | $4.57M | Buy |
59,381
+13,387
| +29% | +$1.03M | 0.01% | 738 |
|
|
2018
Q1 | $2.35M | Buy |
45,994
+4,666
| +11% | +$238K | ﹤0.01% | 856 |
|
|
2017
Q4 | $1.92M | Buy |
41,328
+9,700
| +31% | +$450K | ﹤0.01% | 897 |
|
|
2017
Q3 | $1.69M | Sell |
31,628
-6,100
| -16% | -$325K | ﹤0.01% | 915 |
|
|
2017
Q2 | $2.34M | Buy |
37,728
+1,600
| +4% | +$99.4K | ﹤0.01% | 840 |
|
|
2017
Q1 | $2.45M | Sell |
36,128
-2,600
| -7% | -$176K | ﹤0.01% | 848 |
|
|
2016
Q4 | $2.72M | Buy |
38,728
+100
| +0.3% | +$7.03K | ﹤0.01% | 803 |
|
|
2016
Q3 | $2.74M | Buy |
38,628
+5,409
| +16% | +$384K | ﹤0.01% | 814 |
|
|
2016
Q2 | $1.63M | Buy |
33,219
+5,954
| +22% | +$291K | ﹤0.01% | 887 |
|
|
2016
Q1 | $1.73M | Sell |
27,265
-1,000
| -4% | -$63.3K | ﹤0.01% | 866 |
|
|
2015
Q4 | $3.17M | Sell |
28,265
-700
| -2% | -$78.5K | 0.01% | 759 |
|
|
2015
Q3 | $2.79M | Buy |
28,965
+4,531
| +19% | +$436K | 0.01% | 765 |
|
|
2015
Q2 | $2.5M | Hold |
24,434
| – | – | ﹤0.01% | 816 |
|
|
2015
Q1 | $1.52M | Buy |
24,434
+2,000
| +9% | +$124K | ﹤0.01% | 871 |
|
|
2014
Q4 | $984K | Buy |
22,434
+3,550
| +19% | +$156K | ﹤0.01% | 937 |
|
|
2014
Q3 | $1.07M | Buy |
+18,884
| New | +$1.07M | ﹤0.01% | 894 |
|
|
2014
Q2 | – | Sell |
-5,800
| Closed | -$284K | – | 1311 |
|
|
2014
Q1 | $284K | Buy |
+5,800
| New | +$284K | ﹤0.01% | 1164 |
|